Journal Article

Glucose-mediated insulin secretion is improved in FHL2-deficient mice and elevated FHL2 expression in humans is associated with type 2 diabetes

Habibe, Jayron J, Rampanelli, Elena, Eringa, Etto C, Nieuwdorp, Max, Herrema, Hilde, Vos, Mariska, Clemente-Olivo, Maria P, van Raalte, Daniel H, de Vries, Carlie J. M, Scheithauer, Torsten P. M, Mieremet, Arnout

2022

Overview

Aims/hypothesisThe general population is ageing, involving an enhanced incidence of chronic diseases such as type 2 diabetes. With ageing, DNA methylation of FHL2 increases, as well as expression of the four and a half LIM domains 2 (FHL2) protein in human pancreatic islets. We hypothesised that FHL2 is actively involved in glucose metabolism.MethodsPublicly available microarray datasets from human pancreatic islets were analysed for FHL2 expression. In FHL2-deficient mice, we studied glucose clearance and insulin secretion. Gene expression analysis and glucose-stimulated insulin secretion (GSIS) were determined in isolated murine FHL2-deficient islets to evaluate insulin-secretory capacity. Moreover, knockdown and overexpression of FHL2 were accomplished in MIN6 cells to delineate the underlying mechanism of FHL2 function.ResultsTranscriptomics of human pancreatic islets revealed that individuals with elevated levels of HbA1c displayed increased FHL2 expression, which correlated negatively with insulin secretion pathways. In line with this observation, FHL2-deficient mice cleared glucose more efficiently than wild-type littermates through increased plasma insulin levels. Insulin sensitivity was comparable between these genotypes. Interestingly, pancreatic islets isolated from FHL2-deficient mice secreted more insulin in GSIS assays than wild-type mouse islets even though insulin content and islet size was similar. To support this observation, we demonstrated increased expression of the transcription factor crucial in insulin secretion, MAF BZIP transcription factor A (MafA), higher expression of GLUT2 and reduced expression of the adverse factor c-Jun in FHL2-deficient islets. The underlying mechanism of FHL2 was further delineated in MIN6 cells. FHL2-knockdown led to enhanced activation of forkhead box protein O1 (FOXO1) and its downstream genes such as Mafa and Pdx1 (encoding pancreatic and duodenal homeobox 1), as well as increased glucose uptake. On the other hand, FHL2 overexpression in MIN6 cells blocked GSIS, increased the formation of reactive oxygen species and increased c-Jun activity.Conclusions/interpretationOur data demonstrate that FHL2 deficiency improves insulin secretion from beta cells and improves glucose tolerance in mice. Given that FHL2 expression in humans increases with age and that high expression levels of FHL2 are associated with beta cell dysfunction, we propose that enhanced FHL2 expression in elderly individuals contributes to glucose intolerance and the development of type 2 diabetes.Data availabilityThe human islet microarray datasets used are publicly available and can be found on https://www.ncbi.nlm.nih.gov/geo/.

• Publisher: Springer Nature B.V
• Subject: Aging / Beta cells / c-Jun protein / Chronic illnesses / Diabetes / Diabetes mellitus (non-insulin dependent) / DNA methylation / DNA microarrays / FHL2 protein / Forkhead protein / FOXO1 protein / Gene expression / Genotypes / Geriatrics / Glucose / Glucose metabolism / Glucose tolerance / Glucose transporter / Homeobox / Insulin / Insulin secretion / Intolerance / Pancreas / Reactive oxygen species / Secretion / Transcription factors / Transcriptomics